In situ reprogramming of gut bacteria by oral delivery
It is difficult to precisely target bacterial populations in the mammalian gut. Here the authors use encapsulated phages to deliver dCas9 to E. coli in the mouse gut to modulate RFP expression.
Guardado en:
Autores principales: | Bryan B. Hsu, Isaac N. Plant, Lorena Lyon, Frances M. Anastassacos, Jeffrey C. Way, Pamela A. Silver |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/792e81c6c1904cf7ba9b6609a0a6e187 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Stable Neutralization of a Virulence Factor in Bacteria Using Temperate Phage in the Mammalian Gut
por: Bryan B. Hsu, et al.
Publicado: (2020) -
In situ fabrication of radiopaque microcapsules for oral delivery and real-time gastrointestinal tracking of Bifidobacterium
por: Fang Z, et al.
Publicado: (2018) -
Synthetic CRISPR-Cas gene activators for transcriptional reprogramming in bacteria
por: Chen Dong, et al.
Publicado: (2018) -
Towards the Characterization and Engineering of Bacteriophages in the Gut Microbiome
por: Bryan B. Hsu
Publicado: (2021) -
Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment
por: Zhenping Cao, et al.
Publicado: (2019)